Literature DB >> 6991239

Drug-induced weight gain.

R S Kalucy.   

Abstract

Untoward long term morbidity and mortality and excess non-compliance with treatment may result from the weight gain induced by some drugs used for the treatment of severe psychological disorder. Whilst some weight gain during the recovery from psychological disorder is to be expected, excess weight gain, over and above the patients normal weight, is not necessary to good outcome and can be avoided. Patients vulnerable to excess weight gain can often be identified prior to beginning treatment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6991239     DOI: 10.2165/00003495-198019040-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  7 in total

1.  DRUG-PRODUCED OBESITY. EXPERIENCES WITH CHLORPROMAZINE, PERPHENAZINE AND CLOPENTHIXOL.

Authors:  A AMDISEN
Journal:  Dan Med Bull       Date:  1964-10

2.  Effect of natural oestrogens on blood pressure and weight in postmenopausal women.

Authors:  M Notelovitz
Journal:  S Afr Med J       Date:  1975-12-27

3.  Fat cell number and weight gain in lithium treated patients.

Authors:  P B Vendsborg; N Bach-Mortensen; O J Rafaelsen
Journal:  Acta Psychiatr Scand       Date:  1976-05       Impact factor: 6.392

4.  The use of anabolic steroids by athletes to increase body weight and strength.

Authors:  A J Tahmindjis
Journal:  Med J Aust       Date:  1976-06-26       Impact factor: 7.738

5.  Amitriptyline, weight gain and carbohydrate craving: a side effect.

Authors:  E S Paykel; P S Mueller; P M De la Vergne
Journal:  Br J Psychiatry       Date:  1973-11       Impact factor: 9.319

6.  The effect of cyproheptadine on hunger, calorie intake and body weight in man.

Authors:  T Silverstone; D Schuyler
Journal:  Psychopharmacologia       Date:  1975

7.  Lithium treatment and weight gain.

Authors:  P B Vendsborg; P Bech; O J Rafaelsen
Journal:  Acta Psychiatr Scand       Date:  1976-02       Impact factor: 6.392

  7 in total
  7 in total

1.  Association of prescription H1 antihistamine use with obesity: results from the National Health and Nutrition Examination Survey.

Authors:  Joseph C Ratliff; Jessica A Barber; Laura B Palmese; Erin L Reutenauer; Cenk Tek
Journal:  Obesity (Silver Spring)       Date:  2010-08-12       Impact factor: 5.002

Review 2.  Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications.

Authors:  J M Russell; J A Mackell
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 3.  The pharmacologic management of insomnia in patients with HIV.

Authors:  Toma S Omonuwa; Harold W Goforth; Xavier Preud'homme; Andrew D Krystal
Journal:  J Clin Sleep Med       Date:  2009-06-15       Impact factor: 4.062

Review 4.  Pharmacological management of atypical antipsychotic-induced weight gain.

Authors:  Trino Baptista; Yamily ElFakih; Euderruh Uzcátegui; Ignacio Sandia; Eduardo Tálamo; Enma Araujo de Baptista; Serge Beaulieu
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

5.  Integrative role of the histaminergic system in feeding and taste perception.

Authors:  Tomoko Ishizuka; Atsushi Yamatodani
Journal:  Front Syst Neurosci       Date:  2012-05-24

Review 6.  Interactions between Food and Drugs, and Nutritional Status in Renal Patients: A Narrative Review.

Authors:  Claudia D'Alessandro; Alessia Benedetti; Antonello Di Paolo; Domenico Giannese; Adamasco Cupisti
Journal:  Nutrients       Date:  2022-01-04       Impact factor: 5.717

Review 7.  Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome.

Authors:  Sang Won Jeon; Yong-Ku Kim
Journal:  Int J Mol Sci       Date:  2017-10-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.